Buyer profile
Ministry of Social Affairs and Health
FI- Awards
- 25
- Total awarded value
- €148,258,023
- Countries
- Finland
- Latest award
- Jul 6, 2026
- Expiring within 12 months
- 0
Award history
| Date | Vendor | Title | Category | Value | Country | Expires | Source |
|---|---|---|---|---|---|---|---|
| 07/06/2026 | Viatris Oy | Finland – Vaccines – Seasonal Influenza vaccine 2026-2027 (2027-2028) | Pharmaceuticals | €9.7M | FI | — | View on TED ↗ |
| 09/26/2025 | GlaxoSmithKline Oy | Finland – Vaccines – Meningococcal group A, C, W-135 and Y conjugate vaccine (Men ACWY) 2026-2027 (2028, 2029) | — | €2.5M | FI | — | View on TED ↗ |
| 09/18/2025 | GlaxoSmithKline Oy | Finland – Vaccines – Hepatitis A and B combination Vaccine for adults and children/adolescents 2025-2027 (2027-2028, 2028-2029) | — | €798.3K | FI | — | View on TED ↗ |
| 07/15/2025 | Sanofi Oy | Finland – Vaccines – Diphtheria, tetanus, pertussis and polio (DTaP + IPV) vaccine for children 2026-2027 (2028, 2029) | — | €3.5M | FI | — | View on TED ↗ |
| 03/20/2025 | Pfizer Oy | Finland – Vaccines – Tick-borne Encephalitis (TBE) Vaccine for adults and children 2025 - 2028 | — | €3.2M | FI | — | View on TED ↗ |
| 03/20/2025 | Sanofi Oy | Finland – Vaccines – Diphtheria, Tetanus and Pertussis (acellurar component) Booster (dtap) Vaccine 2025 - 2027 (2027 - 2028 and 2028 - 2029) | — | €5.0M | FI | — | View on TED ↗ |
| 12/02/2024 | Pfizer Oy | Finland – Vaccines – Pneumococcal Conjugate (PCV) Vaccine for children and risk groups 2025-2026 and (2026-2027, 2027-2028) | Pharmaceuticals | €13.8M | FI | — | View on TED ↗ |
| 11/29/2024 | GlaxoSmithKline Oy | Finland – Vaccines – Human Papillomavirus Vaccine (HPV) 2024-2026 (2026-2027 and 2027-2028) | — | €8.1M | FI | — | View on TED ↗ |
| 08/09/2024 | MSD Finland Oy | Finland – Vaccines – Measles, Mumps, Rubella and Varicella (MMRV) combination Vaccine 2024-2026 and (2026-2027, 2027-2028) | — | €10.7M | FI | — | View on TED ↗ |
| 08/09/2024 | MSD Finland Oy | Finland – Vaccines – Varicella vaccine 2025-2026 (2027 and 2028) | — | €8.1M | FI | — | View on TED ↗ |
| 08/09/2024 | Seqirus UK Ltd | Finland – Vaccines – Enhanced Seasonal Influenza Vaccine 2024-2025 (2025-2026, 2026-2027) | — | €6.4M | FI | — | View on TED ↗ |
| 04/10/2024 | MSD Finland Oy | Finland – Vaccines – Rotavirus vaccine 2024 - 2026 (2026 - 2028) | — | €5.8M | FI | — | View on TED ↗ |
| 10/09/2023 | Finland-Helsinki: Vaccines | — | €1.6M | FI | — | View on TED ↗ | |
| 10/06/2023 | Finland-Helsinki: Vaccines | — | €98.6K | FI | — | View on TED ↗ | |
| 10/06/2023 | Finland-Helsinki: Vaccines | — | €300.0K | FI | — | View on TED ↗ | |
| 02/22/2023 | Finland-Helsinki: Vaccines | — | €7.7M | FI | — | View on TED ↗ | |
| 02/20/2023 | Finland-Helsinki: Vaccines | — | €29.9M | FI | — | View on TED ↗ | |
| 12/23/2022 | Finland-Helsinki: Vaccines | — | €1.7M | FI | — | View on TED ↗ | |
| 12/02/2022 | Finland-Helsinki: Vaccines | — | €9.2M | FI | — | View on TED ↗ | |
| 08/19/2022 | Finland-Helsinki: Vaccines | — | €2.5M | FI | — | View on TED ↗ | |
| 08/08/2022 | Finland-Helsinki: Vaccines | — | €12.2M | FI | — | View on TED ↗ | |
| 06/10/2022 | Finland-Helsinki: Vaccines | — | €286.2K | FI | — | View on TED ↗ | |
| 06/03/2022 | Finland-Helsinki: Vaccines | — | €599.9K | FI | — | View on TED ↗ | |
| 05/30/2022 | Finland-Helsinki: Vaccines | — | €1.1M | FI | — | View on TED ↗ | |
| 07/09/2021 | Finland-Valtioneuvosto: Vaccines | — | €3.4M | FI | — | View on TED ↗ |